Features
AI pre-screening of entire EHR for trial eligibility
Automated daily patient matching with evidence
Custom eligibility criteria encoding
HIPAA-compliant data processing
Integration with multiple EHR systems
Patient ranking by likelihood to enroll
Case-specific patient list generation
Supports multiple trial protocols simultaneously
Success-fee pricing model (no upfront costs)
Free implementation and protocol setup for up to 5 trials
Foundation model vBx-1.0 for precision neurology
Multimodal patient brain dataset: 12,000+ brains, 6,000 patients
Paired proteomic, genomic, and clinical data per patient
Physical inventory of 900+ frozen brain tissue samples
Virtual biopsy model predicts brain activity from blood draw
Target discovery from proprietary human data
Target characterization with 83% preclinical validation rate
Biomarker identification for clinical trials
Patient stratification for trial enrichment
Lifts responder fraction from 52% to 69% (vBx-1.0)
Reduces trial enrollment by 43% in Parkinson's (L-DOPA responders)
Platform for target discovery, characterization, biomarkers, and stratification
Supports Parkinson's, Alzheimer's, and other neurodegenerative diseases
Partnership model with top-20 pharma collaborations
